NEWS IN BRIEF J&J receives fresh blow to protect Zytiga against generic entry 28-Nov-2018 By Ben Hargreaves US Court of Appeals knocked down J&J’s efforts to block manufacturers producing generic versions of its product, Zytiga.
J&J hit with patent loss on Zytiga, opening up generics market 30-Oct-2018 By Ben Hargreaves Johnson & Johnson stated it ‘strongly disagreed’ with the US District Court’s decision to rule its Zytiga patent invalid.